Nano-Cap Cancer CompaniesU.S. Exchanges
List of Publicly Traded Nano-Cap Cancer Companies Listed on Major U.S. Exchanges
This list includes companies that provide cancer products and/or services with market capitalizations under 50 million dollars. In the world of investing these are referred to as nano-cap stocks. We update this page at the start of every month so it is possible that during the course of a month a company’s market cap might go above 50 million between updates.
Additional cancer focused companies can be found in our cancer section.
Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:
A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.
Select the company’s link to access charts, news links and company website and social media information.
Cancer: Nano-Cap Stocks
Aethlon Medical, Inc. (AMED) (Diagnostics and therapeutic devices: cancer and infectious diseases)
American Shared Hospital Services (AMS) (Radiosurgical devices and radiosurgery equipment)
Aptevo Therapeutics Inc. (APVO) (Biosciences: oncology and hematology therapies)
Aptose Biosciences, Inc. (APTO) (Canada: therapeutics to treat life-threatening cancers; acute myeloid leukemia, high-risk myelodysplastic syndromes)
Can-Fite Biopharma Ltd (CANF) (Israel: biopharmaceutical company: autoimmune-inflammatory and cancer diseases)
Cel-Sci Corporation (CVM) (Immunotherapy products for the treatment of cancer and infectious diseases)
Cellectar Biosciences, Inc. (CLRB) (Agents to detect, treat and monitor a broad spectrum of cancers)
Celsion Corporation (CLSN) (Oncology company: chemotherapies, immunotherapies and RNA- or DNA-based therapies)
Champions Oncology, Inc. (CSBR) (Solutions and services designed to personalize the development and use of oncology drugs)
Cleveland BioLabs, Inc. (CBLI) (Biopharmaceutical company: toll-like immune receptor activators; applications in radiation mitigation, oncology immunotherapy and vaccines)
Cyclacel Pharmaceuticals, Inc. (CYCC) (Biopharmaceutical company: oral therapies used in the treatment of cancer and other serious diseases)
DelMar Pharmaceuticals, Inc. (DMPI) (Biopharmaceutical company focused on cancer therapies)
Heat Biologics, Inc. (HTBX) (Therapeutic vaccines to combat a wide range of cancers and infectious diseases)
Immune Pharmaceuticals Inc. (IMNP) (Antibody therapeutics: inflammatory diseases and cancer)
ImmunoCellular Therapeutics, Ltd. (IMUC) (Immune-based therapies for the treatment of brain cancers and other cancers)
Kazia Therapeutics (KZIA) (Biotech company: oncology)
MabVax Therapeutics Holdings, Inc. (MBVX) (Monoclonal antibody-based therapeutics and vaccines for cancer)
Moleculin Biotech, Inc. (MBRX) (Clinical stage pharmaceutical company, anticancer drug candidates)
Onconova Therapeutics, Inc. (ONTX) (Biopharmaceutical company: small molecule drug candidates used in the treatment of cancer)
OncoSec Medical Inc. (ONCS) (Technologies designed to stimulate the body’s immune system; cancer)
Sierra Oncology, Inc. (SRRA) (Oncology company)
TapImmune Inc. (TPIV) (Cancer immunotherapies and vaccines)
XTL Biopharmaceuticals Ltd. (XTLB) (Israel, biopharmaceutical company: autoimmune diseases; blood cancer)